These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15271853)

  • 1. STK15 polymorphism and breast cancer risk in a population-based study.
    Egan KM; Newcomb PA; Ambrosone CB; Trentham-Dietz A; Titus-Ernstoff L; Hampton JM; Kimura MT; Nagase H
    Carcinogenesis; 2004 Nov; 25(11):2149-53. PubMed ID: 15271853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of the AURKA (STK15/Aurora Kinase) Gene and Breast Cancer Risk (United States).
    Cox DG; Hankinson SE; Hunter DJ
    Cancer Causes Control; 2006 Feb; 17(1):81-3. PubMed ID: 16411056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of STK15 gene polymorphisms and endogenous estrogen exposure in the risk of breast cancer.
    Dai Q; Cai QY; Shu XO; Ewart-Toland A; Wen WQ; Balmain A; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2065-70. PubMed ID: 15598762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STK15 polymorphisms and association with risk of invasive ovarian cancer.
    Dicioccio RA; Song H; Waterfall C; Kimura MT; Nagase H; McGuire V; Hogdall E; Shah MN; Luben RN; Easton DF; Jacobs IJ; Ponder BA; Whittemore AS; Gayther SA; Pharoah PD; Kruger-Kjaer S
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1589-94. PubMed ID: 15466974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-control, kin-cohort and meta-analyses provide no support for STK15 F31I as a low penetrance colorectal cancer allele.
    Webb EL; Rudd MF; Houlston RS
    Br J Cancer; 2006 Oct; 95(8):1047-9. PubMed ID: 17003782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.
    Justenhoven C; Hamann U; Pesch B; Harth V; Rabstein S; Baisch C; Vollmert C; Illig T; Ko YD; Brüning T; Brauch H
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2059-64. PubMed ID: 15598761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
    Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Phe31Ile polymorphism in Aurora A and risk of breast carcinoma.
    Sun T; Miao X; Wang J; Tan W; Zhou Y; Yu C; Lin D
    Carcinogenesis; 2004 Nov; 25(11):2225-30. PubMed ID: 15271856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
    Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
    Suter NM; Malone KE; Daling JR; Doody DR; Ostrander EA
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):127-35. PubMed ID: 12582022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STK15 F31I polymorphism is associated with increased uterine cancer risk: a pilot study.
    Milam MR; Gu J; Yang H; Celestino J; Wu W; Horwitz IB; Lacour RA; Westin SN; Gershenson DM; Wu X; Lu KH
    Gynecol Oncol; 2007 Oct; 107(1):71-4. PubMed ID: 17599395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases.
    Kelsey KT; Hankinson SE; Colditz GA; Springer K; Garcia-Closas M; Spiegelman D; Manson JE; Garland M; Stampfer MJ; Willett WC; Speizer FE; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):511-5. PubMed ID: 9232338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-carbon metabolism-related gene polymorphisms and risk of breast cancer.
    Suzuki T; Matsuo K; Hirose K; Hiraki A; Kawase T; Watanabe M; Yamashita T; Iwata H; Tajima K
    Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.
    Spurdle AB; Hopper JL; Chen X; Dite GS; McCredie MR; Giles GG; Venter DJ; Southey MC; Purdie DM; Chenevix-Trench G
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1287-93. PubMed ID: 11751447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.
    Kataoka N; Cai Q; Wen W; Shu XO; Jin F; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1148-52. PubMed ID: 16775174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
    Spurdle AB; Hopper JL; Chen X; McCredie MR; Giles GG; Venter DJ; Southey MC; Chenevix-Trench G
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.